이상반응 보고

VAERS ID	1808146
성별	남성
나이	82세
주 코드	MA
제약회사	MODERNA
로트 번호	001A21A
예방접종 횟수	2
접종일	2021-02-26
발병일	2021-08-07
상태	입원 사망

증상

• 집중 치료(Intensive care)
• 무기폐(Atelectasis)
• 흉부 엑스레이 이상(Chest X-ray abnormal)
• SARS-CoV-2 테스트 양성(SARS-CoV-2 test positive)
• 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
• 호흡부전(Respiratory failure)
• 죽음(Death)
• 흉막삼출(Pleural effusion)
• 심장 마비(Cardiac arrest)
• 폐부종(Pulmonary oedema)
• 신장 장애(Renal impairment)
• 급성 심부전(Cardiac failure acute)
• 중복 감염(Superinfection)
• 간 기능 이상(Hepatic function abnormal)

이환 중 질병

N/A

지병

stroke, CAD s/p CABG, ischemic cardiomyopathy, HFrEF, CKD stage III, DM

기타 의료

amiodarone, apixaban, vitamin c, aspirin, atorvastatin, vitamin d3, furosemide, glipizide, insulin lipro, levothyroxine, melatonin, citrucel, metoprolol succinate, omeprazole, trazodone

이전 예방접종

알레르기

cimetidine, tetracycline

임상 검사

covid positive test on 8/7/21 8/7 chest x ray impression: pulmonary edema, large bilateral pleural effusions, and patchy atelectasis in the lower lobe

증상 상세

Patient was transferred to ED on 8/7/21 from rehab after cardiac arrest and then transferred to ICU at another facility.
Arrest was thought to be most likely due to hypoxia iso respiratory failure from ADCHF and superimposed covid infection.
Patient is fully vaccinated.
Patient tested positive for covid on 8/5 but imaging not consistent with covid pneumonia.
Respiratory failure largely driven by large bilateral pleural effusion and pulmonary edema secondary to decompensated heart failure.
Remdesivir was deferred due to renal and hepatic impairment.
Patient was pronounced deceased on 8/11 after family elected to decline further intervention and transition to CMO only on 8/10.